Pomalidomide, bortezomib, and dexamethasone (PVd) in lenalidomide (LEN)-pretreated relapsed refractory multiple myeloma: Subanalysis of patients with renal impairment in OPTIMISMM.Fredrik Schjesvold, Paul G. Richardson, Meral Beksaç et al.|Journal of Clinical Oncology|2020Cited by 2